CLINICAL_TRIALS
trial_result
· 2019-07-29
Clinical Trial Update: Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function [Phase 1]
Summary
Phase 1 pharmacokinetics study evaluating eleclazine in adults with normal and impaired hepatic function.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Long QT Syndrome | Phase 1 | Status: COMPLETED | Results posted: 2019-07-29